Thomas E. Clancy, MD (Hepatobiliary, Pancreas)
Division of Surgical Oncology, Department of Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA;
Gastrointestinal Cancer Center, Dana Farber Cancer Institute
Thomas E. Clancy M.D. is Associate Chief of the Division of Surgical Oncology at Brigham and Women’s Hospital, Surgical Director for Gastrointestinal Cancer at the Dana-Farber/Brigham and Women’s Cancer Center, Co-Director of the Pancreas and Biliary Tumor Program at the Dana-Farber/Brigham and Women’s Cancer Center, and an Assistant Professor of Surgery at Harvard Medical School. Dr. Clancy is a graduate of Holy Cross College and received his medical degree from Harvard Medical School. He completed general surgical residency at Brigham and Women’s Hospital and surgical oncology fellowship at Brigham and Women’s Hospital and Dana-Farber Cancer Institute.
Dr. Clancy specializes in surgery for gastrointestinal malignancies, with a focus on pancreatic tumors, primary and metastatic liver tumors, biliary malignancies, and neuroendocrine tumors. He has a particular interest in developing innovative minimally invasive and robotic surgical techniques for gastrointestinal tumors. Dr. Clancy’s investigative emphasis is on collaborative translational research efforts in gastrointestinal cancer and clinical outcomes studies in surgical oncology. He is co-investigator for an NIH RO1 study of nanoprobes for the diagnosis and treatment of neuroendocrine tumors, and contributing co-investigator of several institutional gastrointestinal research studies including a biobanking protocol for GI malignancy. He has had a significant administrative concentration on the implementation of multidisciplinary care models in oncology care in the outpatient setting.
Dr. Clancy has a major emphasis on surgical education, as a course director for the Harvard Medical School advanced elective in surgical oncology at Brigham and Women’s Hospital, and also in the development and implementation of educational programs in robotic surgery.
Terms of Appointment: Jan 2018 - Dec 2019